Accessibility settings

This paper is in the following e-collection/theme issue:

Clinical Information and Decision Making (3456) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (256) Digital Health Reporting Standards, Quality and Transparency in e-Research (204) Drug Repurposing and Off-Label Use (46)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65872, first published .
Model heart with pills, representing heart health and medication

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Authors of this article:

Huanhuan Ji1 Author Orcid Image ;   Meiling Gong1, 2 Author Orcid Image ;   Li Gong3 Author Orcid Image ;   Ni Zhang4 Author Orcid Image ;   Ruiou Zhou1 Author Orcid Image ;   Dongmei Deng1 Author Orcid Image ;   Ya Yang1 Author Orcid Image ;   Lin Song1 Author Orcid Image ;   Yuntao Jia1 Author Orcid Image
Article Authors Cited by (7) Tweetations Metrics

Journals

  1. Shi W, Zhang Y, Ning J. Robust spurious drug–drug interaction detection via chi-square-guided bidirectional attention mechanism. Engineering Applications of Artificial Intelligence 2025;162:112331 View
  2. Matos C, Ali N, Augusto A, Algarvio R, Figueirinha J, Conceição J. Predictive value of the hERG assay for anticipating the arrhythmogenic potential of new drugs. Drug Discovery Today 2026;31(2):104615 View
  3. Yamazaki S, Onda K, Masuyama K. Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis. Frontiers in Pharmacology 2026;17 View
  4. Liu T, Chen Z, Wang R, Xu X, Gao F, Zu J, Wang Z, Tian Y. Possible clinical drug interactions between ticagrelor and concomitant medications: for adverse drug event monitoring in real-world. Cardiovascular Drugs and Therapy 2026 View
  5. Chen Z, Li Z, Lu Y, Khatra H. Drug–Drug Interaction Signals for Apixaban‐Associated Haemorrhage in Atrial Fibrillation and Thromboembolic Disorders: A Disproportionality Analysis of the FAERS Database. Journal of Interventional Cardiology 2026;2026(1) View
  6. Wu M, Xie L, Lan P, Chen M. Case Report: Amiodarone-triggered refractory ventricular fibrillation storm in septic cardiomyopathy with pre-existing QT prolongation: termination using lidocaine and anisodamine. Frontiers in Medicine 2026;13 View
  7. Qian J, Gong Y, Zhang C, Zhou L. Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database. Frontiers in Medicine 2026;13 View